| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.1B | $4.0B | $4.0B | $4.9B | $5.6B | $1.3B | $0.9B | $0.8B |
| Cost of Revenue | $1.6B | — | — | — | — | — | — | — |
| Gross Profit | $2.1B | $2.2B | $2.1B | $3.0B | $3.8B | $0.9B | $0.2B | $0.4B |
| R&D Expense | $0.2B | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.7B | $0.9B | $0.7B | $1.6B | $2.5B | $1.1B | $-0.1B | $-0.2B |
| Net Income | $0.6B | $0.8B | $0.5B | $1.3B | $1.9B | $0.5B | $-0.1B | $0.1B |
| EPS (Basic) | $2.50 | $3.35 | $1.85 | $5.18 | $7.28 | $4.24 | $-0.76 | $-0.40 |
| EPS (Diluted) | $2.49 | $3.32 | $1.83 | $5.13 | $7.21 | $1.88 | $-0.46 | $0.18 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.0B | $9.2B | $9.1B | $9.1B | $8.9B | $7.2B | $6.4B | $7.2B |
| Current Assets | $3.7B | $3.8B | $4.2B | $3.9B | $3.2B | $2.2B | $1.8B | $1.7B |
| Cash & Equivalents | $2.0B | $2.2B | $2.7B | $2.3B | $1.2B | $0.7B | $0.6B | $0.7B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $1.0B | $1.0B | $1.2B | $0.9B | $1.3B | $1.2B | $1.1B | $1.4B |
| Stockholders' Equity | $5.0B | $5.1B | $5.0B | $4.9B | $4.2B | $2.7B | $2.1B | $2.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $1.3B | $1.1B | $2.1B | $2.3B | $0.9B | $0.6B | $0.7B |
| Investing Cash Flow | $-0.5B | $-0.8B | $-0.2B | $-0.2B | $-1.3B | $-0.1B | $-0.3B | $-0.2B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.8B | $-1.1B | $-0.5B | $-0.8B | $-0.5B | $-0.7B | $-0.4B | $-0.4B |